Below are blood test results since my last BAT update in Sept, 2024. Note the gradually lengthened hiT cycles. ADT (quarterly Eligard shot) is always in the background; darolutamide (Nubeqa) was introduced on the loT cycles in August.
On the 11th of March, I will have completed one full, continuous year on this non-SOC therapy. Side effects are minimal. Energy level and sexual function are good. I have hormone sensitive, metastatic, Gleason 9 PCa, diagnosed in 2019 (see bio for more info).
10-9-24, end of 5th hiT cycle (23 days, 12 Tp injections):
PSA = 0.66
E2 = 3 (should be between 10 and 30)
11-8-24, end of 5th loT cycle (28 days, 3 wks Nubeqa @ half dose, 1 wk washout):
PSA = 0.07
E2 = 21 (using .025 mg/d E2 patch on all loT cycles; loT targeted E2 much easier to hit)
11-22-24, after 2 wks of 6th hiT cycle (7 Tp injections):
PSA = 0.35
E2 = 61 (no letrozole was taken for first 2 wks of loT due to low E2 on previous cycle)
12-13-24, end of 6th hiT cycle (34 days total, 17 Tp injections):
PSA = 0.53
T = 2769 (measured 7 hrs after Tp injection, which varies between 50 and 60 mg)
E2 <2 (.0625 mg letrozole taken 3 days prior to test, confirming high sensitivity to AI)
12-27-24, after 2 wks of 6th loT cycle (with 2 wks of Nubeqa @ half dose):
PSA = 0.11
1-10-25, end of 6th loT cycle (28 days total, 3 wks Nubeqa @ half dose, 1 wk washout):
PSA = 0.05
E2 = 19
1-24-25, after 2 wks of 7th hiT cycle (8 Tp injections):
PSA = 0.33
E2 = 2 (having difficulty adjusting timing of letrozole dose)
2-7-25, after 4 wks of 7th hiT cycle (15 Tp injections):
PSA = 0.44
E2 = 47
2-21-25, end of 7th hiT cycle (42 days total, 22 Tp injections):
PSA = 0.58
E2 = 23 (.03 mg letrozole taken 2 wks prior to BT; 1/8th of a pill hard to accurately split)
Please let me know if you have any thoughts, questions, or suggestions.